Last 12 months
Inside the activity.
7 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 2 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 2 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2020 Filed Aug 26, 2020 14:37 UTC |
Suskind DennisDirector
|
SaleCommon Stock Class A | 2,000 | $174.61 | $349,220.00 |
DisclosureSEC source: 0001156375-20-000086 · edgardoc.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,565 Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 14:41 UTC |
GLICKMAN DANIEL RDirector
|
SaleCommon Stock Class A | 900 | $173.22 | $155,898.00 |
DisclosureSEC source: 0001156375-20-000085 · edgardoc.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,405 Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 22:14 UTC |
Carey Charles PDirector
|
SaleCommon Stock Class A | 2,000 | $168.01 | $336,020.00 |
DisclosureSEC source: 0001156375-20-000084 · edgardoc.xml · nonDerivative · entry 2 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Firm Disclosed balance after: 6,141 F2 · price: On August 11, 2020, Mr. Carey sold an aggregate of 2,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $167.98 to $168.11. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:14 UTC |
Carey Charles PDirector
|
SaleCommon Stock Class A | 6,000 | $164.51 | $987,060.00 |
DisclosureSEC source: 0001156375-20-000084 · edgardoc.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Firm Disclosed balance after: 8,141 F1 · price: On August 10, 2020, Mr. Carey sold an aggregate of 6,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $163.90; $164.00 to $164.85; and $165.00 to $165.50. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| June 26, 2020 Filed Jun 21, 2021 06:05 UTC |
Dennis Michael G.Director
|
OtherCommon Stock Class A | 0.2052 | $166.59 | $34.18 |
DisclosureSEC source: 0000899243-21-024607 · doc5.xml · nonDerivative · entry 2 Dennis Michael G. · CIK 0001811883 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Spouse Disclosed balance after: 40.4104 F1 · kind: Acquisition of shares under a broker-administered dividend reinvestment plan. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 18:09 UTC |
Dennis Michael G.Director
|
GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000054 · edgardoc.xml · nonDerivative · entry 1 Dennis Michael G. · CIK 0001811883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 752.2059 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 18:11 UTC |
GERDES LARRY GDirector
|
GrantCommon Stock Class A | 1,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000057 · edgardoc.xml · nonDerivative · entry 1 GERDES LARRY G · CIK 0000925105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,934.15 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 18:13 UTC |
SAVAGE TERRY LDirector
|
GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000065 · edgardoc.xml · nonDerivative · entry 1 SAVAGE TERRY L · CIK 0001094549 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 17,839 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:08 UTC |
CHOOKASZIAN DENNISDirector
|
GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000053 · edgardoc.xml · nonDerivative · entry 1 CHOOKASZIAN DENNIS · CIK 0001120026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,815 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:15 UTC |
Tierney Robert J JRDirector
|
GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000070 · edgardoc.xml · nonDerivative · entry 1 Tierney Robert J JR · CIK 0001776581 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,318 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:15 UTC |
Suskind DennisDirector
|
GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000069 · edgardoc.xml · nonDerivative · entry 1 Suskind Dennis · CIK 0001361519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,565 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:14 UTC |
SHEPARD WILLIAM RDirector
|
GrantCommon Stock Class A | 1,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000067 · edgardoc.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 197,059.695 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:14 UTC |
SIEGEL HOWARD JDirector
|
GrantCommon Stock Class A | 1,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000068 · edgardoc.xml · nonDerivative · entry 1 SIEGEL HOWARD J · CIK 0001212853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,568 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:14 UTC |
Seifu RahaelDirector
|
GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000066 · edgardoc.xml · nonDerivative · entry 1 Seifu Rahael · CIK 0001812194 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 712 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:13 UTC |
Maloney Patrick WDirector
|
GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000063 · edgardoc.xml · nonDerivative · entry 1 Maloney Patrick W · CIK 0001812087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 716 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:13 UTC |
Mulchrone Patrick JDirector
|
GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000064 · edgardoc.xml · nonDerivative · entry 1 Mulchrone Patrick J · CIK 0001812174 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,103 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:12 UTC |
Lucas Deborah JDirector
|
GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000062 · edgardoc.xml · nonDerivative · entry 1 Lucas Deborah J · CIK 0001329150 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,006 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:12 UTC |
Lockett Phyllis MDirector
|
GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000061 · edgardoc.xml · nonDerivative · entry 1 Lockett Phyllis M · CIK 0001776684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,318 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:12 UTC |
Hobert William WDirector
|
GrantCommon Stock Class A | 1,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000059 · edgardoc.xml · nonDerivative · entry 1 Hobert William W · CIK 0001643402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,002 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:12 UTC |
Kaye Daniel GDirector
|
GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000060 · edgardoc.xml · nonDerivative · entry 1 Kaye Daniel G · CIK 0001556974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,318 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:10 UTC |
GEPSMAN MARTIN JDirector
|
GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000056 · edgardoc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,617 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:11 UTC |
GLICKMAN DANIEL RDirector
|
GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000058 · edgardoc.xml · nonDerivative · entry 1 GLICKMAN DANIEL R · CIK 0001212819 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,305 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:10 UTC |
Dutra AnaDirector
|
GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000055 · edgardoc.xml · nonDerivative · entry 1 Dutra Ana · CIK 0001426393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,885 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:08 UTC |
Carey Charles PDirector
|
GrantCommon Stock Class A | 1,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000052 · edgardoc.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 3,727 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 21:50 UTC |
Cook Elizabeth ADirector
|
GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000051 · edgardoc.xml · nonDerivative · entry 1 Cook Elizabeth A · CIK 0001643475 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 22,139 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 21:42 UTC |
Bitsberger Timothy S.Director
|
GrantCommon Stock Class A | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000050 · edgardoc.xml · nonDerivative · entry 1 Bitsberger Timothy S. · CIK 0001434852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,139 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Nov 8, 2022 22:32 UTC |
SHEPARD WILLIAM RDirector
|
OtherCommon Stock Class A | 3.932 | $166.66 | $655.31 |
DisclosureSEC source: 0001156375-22-000314 · wf-form5_166794671094843.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,003.932 F1 · kind: Acquisition of shares under a broker-administered dividend reinvestment plan. Read SEC document |
| June 12, 2020 Filed Feb 12, 2021 20:06 UTC |
Sammann DerekSr MD Gl Hd Commodity & Option
|
OtherCommon Stock Class A | 5,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-21-000011 · edgardoc.xml · nonDerivative · entry 4 Sammann Derek · CIK 0001475318 · Sr MD Gl Hd Commodity & Option 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 21,811 F3 · shares: Ownership has been updated to reflect the transfer of CME Group Class A common stock to reporting person's revocable living trust. Read SEC document |
| June 12, 2020 Filed Feb 12, 2021 20:06 UTC |
Sammann DerekSr MD Gl Hd Commodity & Option
|
GiftCommon Stock Class A | 4,485 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-21-000011 · edgardoc.xml · nonDerivative · entry 2 Sammann Derek · CIK 0001475318 · Sr MD Gl Hd Commodity & Option 10b5-1 filing: Not disclosed Ownership: Indirect · by Spouse Disclosed balance after: 16,394 F2 · ownership.nature: This transaction represented a gift of securities from the reporting person to his spouse. The reporting person disclaims beneficial ownership of the shares held by his spouse, and this report shall not be deemed as an admission that the reporting person is the beneficial owner of his spouse's shares for purposes of Section 16 or for any other purpose. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 15:44 UTC |
SHEPARD WILLIAM RDirector
|
PurchaseCommon Stock Class A | 1,229 | $178.10 | $218,884.90 |
DisclosureSEC source: 0001156375-20-000049 · edgardoc.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| June 08, 2020 Filed Jun 11, 2020 18:31 UTC |
Bitsberger Timothy S.Director
|
SaleCommon Stock Class A | 500 | $191.32 | $95,660.00 |
DisclosureSEC source: 0001156375-20-000048 · edgardoc.xml · nonDerivative · entry 2 Bitsberger Timothy S. · CIK 0001434852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,427 Read SEC document |
| June 08, 2020 Filed Jun 11, 2020 18:31 UTC |
Bitsberger Timothy S.Director
|
SaleCommon Stock Class A | 100 | $191.29 | $19,129.00 |
DisclosureSEC source: 0001156375-20-000048 · edgardoc.xml · nonDerivative · entry 1 Bitsberger Timothy S. · CIK 0001434852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,927 Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 16:12 UTC |
Holzrichter JulieSr MD Chief Operating Officer
|
SaleCommon Stock Class A | 3,090 | $190.31 | $588,057.90 |
DisclosureSEC source: 0001156375-20-000046 · edgardoc.xml · nonDerivative · entry 1 Holzrichter Julie · CIK 0001409442 · Sr MD Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,001 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F2 · price: On June 5, 2020, Ms. Holzrichter sold an aggregate of 3,090 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $188.14 to $188.94; $189.07 to $189.99; $190.03 to $190.97; $191.23 to $191.72 and $192.05 to $192.76. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 23:52 UTC |
SHEPARD WILLIAM RDirector
|
PurchaseCommon Stock Class A | 771 | $178.10 | $137,315.10 |
DisclosureSEC source: 0001156375-20-000045 · primary_doc.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 771 Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:26 UTC |
Durkin Bryan TDirector
|
SaleCommon Stock Class A | 9,000 | $180.11 | $1,620,990.00 |
DisclosureSEC source: 0001156375-20-000044 · edgardoc.xml · nonDerivative · entry 1 Durkin Bryan T · CIK 0001341363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,150 F1 · price: On May 21, 2020, Mr. Durkin sold an aggregate of 9,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $179.00 to $179.93 and $180.03 to $180.96 The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| April 06, 2020 Filed Apr 7, 2020 19:43 UTC |
Holzrichter JulieSr MD Chief Operating Officer
|
SaleCommon Stock Class A | 3,011 | $180.00 | $541,980.00 |
DisclosureSEC source: 0001156375-20-000031 · edgardoc.xml · nonDerivative · entry 1 Holzrichter Julie · CIK 0001409442 · Sr MD Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,091 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 20:41 UTC |
Vroman KenSr MD International & Optimiza
|
GrantCommon Stock Class A | 1,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000029 · edgardoc.xml · nonDerivative · entry 5 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,857 Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:53 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
Tax withholdingCommon Stock Class A | 178 | $182.01 | $32,397.78 |
DisclosureSEC source: 0001156375-20-000030 · edgardoc.xml · nonDerivative · entry 9 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,424 F4 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/20. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:53 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
Tax withholdingCommon Stock Class A | 802 | $182.01 | $145,972.02 |
DisclosureSEC source: 0001156375-20-000030 · edgardoc.xml · nonDerivative · entry 8 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,602 F2 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:53 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
GrantCommon Stock Class A | 1,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000030 · edgardoc.xml · nonDerivative · entry 7 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,404 F3 · shares: Represents shares earned from a 2017 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2017-2019. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:53 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
Tax withholdingCommon Stock Class A | 802 | $182.01 | $145,972.02 |
DisclosureSEC source: 0001156375-20-000030 · edgardoc.xml · nonDerivative · entry 6 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,594 F2 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:53 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
GrantCommon Stock Class A | 1,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000030 · edgardoc.xml · nonDerivative · entry 5 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,396 F3 · shares: Represents shares earned from a 2017 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2017-2019. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:53 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
Tax withholdingCommon Stock Class A | 909 | $182.01 | $165,447.09 |
DisclosureSEC source: 0001156375-20-000030 · edgardoc.xml · nonDerivative · entry 4 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,586 F2 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:53 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
GrantCommon Stock Class A | 2,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000030 · edgardoc.xml · nonDerivative · entry 3 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,495 F1 · shares: Represents shares earned from a 2016 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2017-2019. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:53 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
Tax withholdingCommon Stock Class A | 909 | $182.01 | $165,447.09 |
DisclosureSEC source: 0001156375-20-000030 · edgardoc.xml · nonDerivative · entry 2 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,445 F2 · shares: Ms. Winkler surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:53 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
GrantCommon Stock Class A | 2,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000030 · edgardoc.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,354 F1 · shares: Represents shares earned from a 2016 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2017-2019. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:41 UTC |
Vroman KenSr MD International & Optimiza
|
Tax withholdingCommon Stock Class A | 282 | $182.01 | $51,326.82 |
DisclosureSEC source: 0001156375-20-000029 · edgardoc.xml · nonDerivative · entry 4 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,721 F2 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:41 UTC |
Vroman KenSr MD International & Optimiza
|
GrantCommon Stock Class A | 960 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000029 · edgardoc.xml · nonDerivative · entry 3 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,003 F1 · shares: Represents shares earned from a 2016 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2017-2019. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:41 UTC |
Vroman KenSr MD International & Optimiza
|
Tax withholdingCommon Stock Class A | 282 | $182.01 | $51,326.82 |
DisclosureSEC source: 0001156375-20-000029 · edgardoc.xml · nonDerivative · entry 2 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,043 F2 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:41 UTC |
Vroman KenSr MD International & Optimiza
|
GrantCommon Stock Class A | 960 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000029 · edgardoc.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,325 F1 · shares: Represents shares earned from a 2016 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2017-2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.